from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2817c/-

LFCtreatmentdescriptionclass of inhibitor

-0.118

Amikacinug/mL Amikacintranslation

0.349

Cap5-10ug/mL Capreomycintranslation

0.550

Rox10-50 ug/mL Roxithromycintranslation

0.185

SM2-5 ug/mL Streptomycintranslation

0.000

Tet5-10 ug/mL Tetracyclinetranslation

-0.184

Rif0.2-5ug/mL Rifampicintranscription

0.633

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.000

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.659

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.148

CPZ10-50 ug/mL Chlorpromazinerespiration

0.000

Clofazimine10-13 ug/mL Clofaziminerespiration

0.578

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.000

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.000

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.011

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.000

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.585

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.555

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.675

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.000

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

0.418

Nigericin50 uM Nigericinrespiration

0.409

TRC10-150 ug/mL Triclosanrespiration

0.000

TRZ10-25 ug/mL Thioridazinerespiration

-0.025

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.057

menadione6-10 ug/mL Menadionerespiration

0.125

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.256

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.204

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

1.451

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.217

NRP_1Non-replicating persistence stage 1dosRassociated

0.908

Amp0.2mg/mL AmpicillincellWall

0.068

Cephalexin20-100 ug/mL CephalexincellWall

1.775

Cerulenin0.32-5 ug/mL CerulenincellWall

0.638

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

1.050

EMB10-20 ug/mL EthambutolcellWall

-0.115

Eta12-40 ug/mL EthionamidecellWall

-0.245

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.198

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.000

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.000

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.163

BZA0.12 mg/mL BenzamidearomaticAmides

-0.759

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.126

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.595

H2O24 mM hydrogen peroxideDNAdamaging

-0.040

Levo10 ug/mL LevofloxacinDNAdamaging

-0.659

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.000

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.386

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.796

UVUV-irradiationDNAdamaging

0.000

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.613

Antimycin12.5-50 ug/mL Antimycin A?

1.023

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.203

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.511

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.093

PA8240.2-2 ug/mL PA-824?

2.063

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.139

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-1.686

Verapamil50 uM Verapamil?

-1.304

mercaptoethanol2 mM 2-Mercaptoethanol?

1.363

methoxatin10-20 ug/mL Methoxatin?